Most Covid-19 patients discharged from hospital still have symptoms a month later, according to SA's first study of 'long Covid'.
National Institute for Communicable Diseases
More than half told researchers who interviewed them on the telephone that they were eating more healthily, and one in five said they were drinking less alcohol.Image:Obesity and the presence of four or more symptoms during the virus' acute phase were the factors most closely associated with patients' non-recovery.
The team plans to follow the progress of the patients for a year and said its work would contribute to the development of clinical guidelines, the establishment of multidisciplinary health services, training of healthcare workers and the provision of information and support to patients. They had all been hospitalised for at least a day, tested positive and been discharged between December 2020 and April 2021. Two-thirds had been in private hospitals, and higher proportions came from the 40-64 age group and those who had been treated in ICU and given oxygen.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
SA records over 12 300 new Covid-19 cases, 271 deaths on Saturday12 371 new Covid-19 cases reported in South Africa on Saturday, and 271 deaths.
Read more »
India approves J&J's single-shot Covid-19 vaccine for emergency useIndia gave emergency approval to Johnson and Johnson's single-shot coronavirus vaccine Saturday to ramp up its flailing immunisation campaign as fe...
Read more »
Vaccines in Gauteng: Where to get your Covid-19 jab this weekendICYMI: Here's where to get your Covid-19 jab in Gauteng this weekend.
Read more »
Ekurhuleni sub-districts record spike in Covid-19 deathsThe Gauteng Health department warns of a rise in Covid-19 infections and calls on members to be vigilant.
Read more »
J&J Covid-19 vaccine works against DeltaHealthcare workers had 91% to 96.2% protection against sickness and death she said, presenting the first results in the world to show J&J’s effectiveness against the Delta variant.
Read more »